September 6, 2012
Dainippon Sumitomo Pharma (DSP) announced on September 5 that it submitted on August 21 an imported drug registration application to the State Food and Drug Administration (SFDA) of China for the anticancer antibiotic amrubicin HCl (brand name in Japan: Calsed)...read more